VistaGen welcomes new stem cell technique 

H. Ralph Snodgress, president and CEO of South San Francisco’s VistaGen Therapeutics Inc., said he welcomed news of a discovery reported this week that allows adult skin cells to be reprogrammed into human universal cells.

While VistaGen uses embryonic stem cells in its work developing treatments for diabetes and neurological disorders, Snodgrass said the new technique would complement the company’s work.

"Any new discovery or technology that enables the generation of diverse embryonic stem cells, especially those unique to specific diseases, is very useful," he said.

About The Author

Staff Report

Staff Report

Bio:
A daily newspaper covering San Francisco, San Mateo County and serving Alameda, Marin and Santa Clara counties.
Pin It
Favorite

Speaking of Business

More by Staff Report

Latest in Business & Real Estate

© 2018 The San Francisco Examiner

Website powered by Foundation